| Sub Cat | Immunogen | Isotype | Application | Affinity | |
|---|---|---|---|---|---|
| V3S-1124-YC161 | IgG1 kappa | ELISA; WB; Neut | |||
| V3S-0522-YC1635 | IgG | Inhib | 0.815 nM | ||
| V3S-0522-YC1636 | IgG | Inhib | 3.09 nM | ||
| V3S-0522-YC1638 | IgG | Inhib | 9.02 nM | ||
| V3S-0522-YC1777 | IgG | ELISA; Inhib | 22.5 pM | ||
| V3S-0522-YC1778 | IgG | ELISA; Inhib | 28.8 pM | ||
| V3S-0522-YC1779 | IgG | ELISA; Inhib | 23.3 pM | ||
| V3S-0522-YC1780 | IgG | ELISA; Inhib | 97.1 pM | ||
| V3S-0622-YC1993 | IgG | IP; IF; FuncS; FC; Neut; ELISA; WB | |||
| V3S-0622-YC4868 | Recombinant human soluble extracellular KDR (110 kDa) native protein. | IgG | IF; IP; Neut; FuncS; ELISA; FC; ICC | ||
| V3S-0522-YC1334 | IgG1 kappa | ELISA; FC | |||
| V3S-0522-YC1342 | Soluble KDR | IgG2 | ELISA; FC | ||
| V3S-0522-YC1413 | IgG | ELISA | |||
| V3S-0522-YC1776 | IgG | ELISA | |||
| V3S-0622-YC313 | A complex of equimolar amounts of KDR and VEGF. | IgG1 | ELISA; FC | 1 nM | |
| V3S-0622-YC3596 | IgG1 kappa | ELISA; WB | |||
| V3S-0622-YC4054 | IgG | ELISA | |||
| V3S-1022-YC162 | IgG1 | ELISA | 0.567 nM | ||
| V3S-1022-YC163 | IgG1 | ELISA | 0.211 nM | ||
| V3S-1022-YC165 | IgG1 | ELISA | 0.425 nM | ||
| V3S-1022-YC167 | IgG1 | ELISA | 0.277 nM |
| Description | This product is a monoclonal antibody derived from Human (Homo sapiens), which can specifically recognize Kinase insert domain receptor. The antibody is expressed with mammalian cell transient expression system, serum-free and purified by affinity chromatography. The purity and integrity are tested via SDS-PAGE and SEC-HPLC analysis. Given an antigen, additional QC measures are also desired such as affinity testing and binding validation. Specifically, the antibody is provided in multiple formats for in vivo and in vitro assays. The Invivo version features greater than 95% purity, ultra-low endotoxin levels (<1 EU/mg or 0.1 EU/mg), and is preservative, stabilizer, and carrier protein-free. |
| Clonality | Monoclonal |
| Host Species | Human |
| Target Species | Human |
| Isotype | IgG1, κ |
| Expression Species | HEK293F or CHO |
| Conjugation | None |
| Purity | >95%, determined by SDS-PAGE and/or SEC-HPLC |
| Endotoxin | <1 EU/mg, determined by LAL method |
| Purification | Protein A affinity purified |
| Sterility | 0.2 μM filtered |
| Formulation | PBS, pH 7.4 |
| Preservation | No preservatives |
| Stabilizer | No stabilizers |
| Storage | Store at 4⁰C within a week. For longer storage, aliquot and store at -20⁰C. |
| Application | ELISA; WB; Neut |
| Application Notes | The antibody is recommended for detection of KDR by ELISA, WB, Neut assays. |
| ELISA | Enzyme-Linked Immunosorbent Assay Protocol |
| WB | Western Blot Protocol |
| FC | Flow Cytometry Protocol |
| Target | KDR |
| Alternative Name | KDR; kinase insert domain receptor; FLK1; CD309; VEGFR; VEGFR2; vascular endothelial growth factor receptor 2; soluble VEGFR2; fetal liver kinase 1; fetal liver kinase-1; protein-tyrosine kinase receptor Flk-1; tyrosine kinase growth factor receptor; kinase insert domain receptor (a type III receptor tyrosine kinase) |
| Gene ID | 3791 |
| UniProt | P35968 |
| Research Area | Cardiovascular |
| Related Disease | Leukemia |
